Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Oligonucleotide Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Arrowhead Pharmaceuticals
GlaxoSmithKline
Ionis Pharmaceuticals
miRagen Therapeutics
Biogen
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Antisense/RNAi oligonucleotides
Others
Application:
Neurological disorders
Cancer
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Oligonucleotide Therapeutics Industry Overview
-
1.1.1 Oligonucleotide Therapeutics Market Scope and Market Segments
-
1.1.2 Oligonucleotide Therapeutics Industry Characteristics
-
1.1.3 Global and China Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Oligonucleotide Therapeutics Production Value and Growth Rate (2017-2028)
-
1.2 Global Oligonucleotide Therapeutics Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Antisense/RNAi oligonucleotides
-
1.2.2 Others
-
1.3 Global Oligonucleotide Therapeutics Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Neurological disorders
-
1.3.2 Cancer
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Oligonucleotide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Oligonucleotide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Oligonucleotide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Oligonucleotide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Oligonucleotide Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Oligonucleotide Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Oligonucleotide Therapeutics Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Oligonucleotide Therapeutics Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Oligonucleotide Therapeutics Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Oligonucleotide Therapeutics Industry Porter's Five Forces Model Analysis
-
2.2.3 Oligonucleotide Therapeutics Industry PEST Analysis
-
2.3 Oligonucleotide Therapeutics Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Oligonucleotide Therapeutics Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Oligonucleotide Therapeutics Industry
Chapter 3 Global and China Oligonucleotide Therapeutics Market, by Manufacturer
-
3.1 Global and China Oligonucleotide Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Oligonucleotide Therapeutics Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Oligonucleotide Therapeutics Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Oligonucleotide Therapeutics Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Oligonucleotide Therapeutics Market Top 3 Players
Chapter 4 Global and China Oligonucleotide Therapeutics Market, by Type (2017-2028)
-
4.1 Oligonucleotide Therapeutics Market Trend, by Type
-
4.2 Global Oligonucleotide Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Oligonucleotide Therapeutics Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Oligonucleotide Therapeutics Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Oligonucleotide Therapeutics Price Trend, by Type (2017-2028)
-
4.3 China Oligonucleotide Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Oligonucleotide Therapeutics Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Oligonucleotide Therapeutics Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Oligonucleotide Therapeutics Price Trend, by Type (2017-2028)
Chapter 5 Global and China Oligonucleotide Therapeutics Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Oligonucleotide Therapeutics Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Oligonucleotide Therapeutics Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Oligonucleotide Therapeutics Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Oligonucleotide Therapeutics Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Oligonucleotide Therapeutics Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Oligonucleotide Therapeutics Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Oligonucleotide Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Oligonucleotide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Oligonucleotide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Oligonucleotide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Oligonucleotide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Oligonucleotide Therapeutics Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Oligonucleotide Therapeutics Market Analysis
-
7.1 North America Oligonucleotide Therapeutics Market, by Type
-
7.2 North America Oligonucleotide Therapeutics Market, by Application
-
7.3 North America Oligonucleotide Therapeutics Market Analysis and Forecast, by Country
-
7.3.1 United States Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Oligonucleotide Therapeutics Market Analysis
-
8.1 Europe Oligonucleotide Therapeutics Market, by Type
-
8.2 Europe Oligonucleotide Therapeutics Market, by Application
-
8.3 Europe Oligonucleotide Therapeutics Market Analysis and Forecast, by Country
-
8.3.1 Germany Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Oligonucleotide Therapeutics Market Analysis
-
9.1 APAC Oligonucleotide Therapeutics Market, by Type
-
9.2 APAC Oligonucleotide Therapeutics Market, by Application
-
9.3 APAC Oligonucleotide Therapeutics Market Analysis and Forecast, by Country
-
9.3.1 China Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Oligonucleotide Therapeutics Market Analysis
-
10.1 Latin America, Middle East and Africa Oligonucleotide Therapeutics Market, by Type
-
10.2 Latin America, Middle East and Africa Oligonucleotide Therapeutics Market, by Application
-
10.3 Latin America, Middle East and Africa Oligonucleotide Therapeutics Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Oligonucleotide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Oligonucleotide Therapeutics Company Profiles
-
11.1 Arrowhead Pharmaceuticals
-
11.1.1 Arrowhead Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Arrowhead Pharmaceuticals Oligonucleotide Therapeutics Product Profiles, Application and Specification
-
11.1.3 Arrowhead Pharmaceuticals Oligonucleotide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 GlaxoSmithKline
-
11.2.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 GlaxoSmithKline Oligonucleotide Therapeutics Product Profiles, Application and Specification
-
11.2.3 GlaxoSmithKline Oligonucleotide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Ionis Pharmaceuticals
-
11.3.1 Ionis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Ionis Pharmaceuticals Oligonucleotide Therapeutics Product Profiles, Application and Specification
-
11.3.3 Ionis Pharmaceuticals Oligonucleotide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 miRagen Therapeutics
-
11.4.1 miRagen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 miRagen Therapeutics Oligonucleotide Therapeutics Product Profiles, Application and Specification
-
11.4.3 miRagen Therapeutics Oligonucleotide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Biogen
-
11.5.1 Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Biogen Oligonucleotide Therapeutics Product Profiles, Application and Specification
-
11.5.3 Biogen Oligonucleotide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Oligonucleotide Therapeutics Industry Investment Prospect and Risk Assessment
-
12.1 Oligonucleotide Therapeutics Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Oligonucleotide Therapeutics Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure China Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Production Value and Growth Rate (2017-2028)
-
Figure China Oligonucleotide Therapeutics Production Value and Growth Rate (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Market Size and Growth Rate of Antisense/RNAi oligonucleotides (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Market Size and Growth Rate of Neurological disorders (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Market Size and Growth Rate of Cancer (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Oligonucleotide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Oligonucleotide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Oligonucleotide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Oligonucleotide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Oligonucleotide Therapeutics Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Oligonucleotide Therapeutics Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Oligonucleotide Therapeutics Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Oligonucleotide Therapeutics Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Oligonucleotide Therapeutics Market Share, by Manufacturer in 2021
-
Figure Global and China Oligonucleotide Therapeutics Market Share, by Manufacturer in 2022
-
Table Global Oligonucleotide Therapeutics Sales Volume, by Type (2017-2028)
-
Table Global Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Global Oligonucleotide Therapeutics Sales Value, by Type (2017-2028)
-
Table Global Oligonucleotide Therapeutics Sales Value Share, by Type (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Price Trend, by Type (2017-2028)
-
Table China Oligonucleotide Therapeutics Sales Volume, by Type (2017-2028)
-
Table China Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure China Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table China Oligonucleotide Therapeutics Sales Value, by Type (2017-2028)
-
Table China Oligonucleotide Therapeutics Sales Value Share, by Type (2017-2028)
-
Figure China Oligonucleotide Therapeutics Price Trend, by Type (2017-2028)
-
Table Global Oligonucleotide Therapeutics Sales Volume, by Application (2017-2028)
-
Table Global Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Table Global Oligonucleotide Therapeutics Sales Value, by Application (2017-2028)
-
Table Global Oligonucleotide Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure Global Oligonucleotide Therapeutics Sales Value Share, by Application (2017-2028)
-
Table China Oligonucleotide Therapeutics Sales Volume, by Application (2017-2028)
-
Table China Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure China Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Table China Oligonucleotide Therapeutics Sales Value, by Application (2017-2028)
-
Table China Oligonucleotide Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure China Oligonucleotide Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure China Oligonucleotide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure North America Oligonucleotide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Oligonucleotide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Oligonucleotide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Oligonucleotide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Table North America Oligonucleotide Therapeutics Sales Volume, by Type (2017-2028)
-
Table North America Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure North America Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table North America Oligonucleotide Therapeutics Sales Volume, by Application (2017-2028)
-
Table North America Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure North America Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure United States Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure United States Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Canada Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Europe Oligonucleotide Therapeutics Sales Volume, by Type (2017-2028)
-
Table Europe Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Europe Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Europe Oligonucleotide Therapeutics Sales Volume, by Application (2017-2028)
-
Table Europe Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Europe Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Germany Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure UK Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure UK Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure France Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure France Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Italy Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Spain Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Poland Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Russia Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table APAC Oligonucleotide Therapeutics Sales Volume, by Type (2017-2028)
-
Table APAC Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure APAC Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table APAC Oligonucleotide Therapeutics Sales Volume, by Application (2017-2028)
-
Table APAC Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure APAC Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure China Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure China Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Japan Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure India Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure India Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Oligonucleotide Therapeutics Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Oligonucleotide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Oligonucleotide Therapeutics Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Oligonucleotide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Oligonucleotide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Oligonucleotide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Arrowhead Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Arrowhead Pharmaceuticals Product Profiles, Application and Specification
-
Table Arrowhead Pharmaceuticals Oligonucleotide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline Product Profiles, Application and Specification
-
Table GlaxoSmithKline Oligonucleotide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ionis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ionis Pharmaceuticals Product Profiles, Application and Specification
-
Table Ionis Pharmaceuticals Oligonucleotide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table miRagen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table miRagen Therapeutics Product Profiles, Application and Specification
-
Table miRagen Therapeutics Oligonucleotide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biogen Product Profiles, Application and Specification
-
Table Biogen Oligonucleotide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
